MedTrace Logo

PENG Block vs. ESP Block for Pediatric Hip Surgery

NCT06087549 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-02-28

No results posted yet for this study

Summary

The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries.

Conditions

  • Hip Dysplasia
  • Hip Injuries
  • Hip Fractures
  • Hip Disease

Interventions

DRUG

Pericapsular nerve group block using 0.2% ropivacaine

Unilateral ultrasound guided pericapsular nerve block using 0.5mL/kg 0.2% Ropimol (max 20mL)

DRUG

Erector Spinae Plane Block using 0.2% ropivacaine

Unilateral ultrasound guided erector spinae block using 0.5mL/kg 0.2% Ropimol (max 20mL)

OTHER

Standard care

No erector spinae block and no pericapsular nerve group block

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Tomasz Kotwicki, Prof.dr hab · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2024-02-23
Completion
2024-02-23

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087549 on ClinicalTrials.gov